Five-Year Clinical Outcomes for Resolute Zotarolimus-Eluting Stents in Total Occlusions

被引：0
|
作者：
Yeh, Robert [1 ]
Kelbaek, Henning [2 ]
Neumann, Franz-Josef [3 ]
Serruys, Patrick [4 ]
Windecker, Stephan [5 ]
Belardi, Jorge [6 ]
Xu, Bo [7 ]
Qiao, Shubin [7 ]
Liu, Minglei
Silber, Sigmund [8 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Zealand Univ Hosp, Roskilde, Denmark
[3] Univ Heart Ctr Freiburg Bad Krozingen, Cardiol, Bad Krozingen, Germany
[4] Imperial Coll, London, England
[5] Univ Hosp Bern, Bern, Switzerland
[6] Inst Cardiovasc Buenos Aires, Buenos Aires, DF, Argentina
[7] Fu Wai Hosp, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
[8] Heart Ctr Isar, Munich, Germany
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 72卷 / 13期
关键词：
D O I：
10.1016/j.jacc.2018.08.1244
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-137
引用
收藏
页码：B59 / B59
页数：1
相关论文
共 50 条
  • [41] Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial
    Harada, Yukinori
    Colleran, Roisin
    Kufner, Sebastian
    Giacoppo, Daniele
    Rheude, Tobias
    Michel, Jonathan
    Cassese, Salvatore
    Ibrahim, Tareq
    Laugwitz, Karl-Ludwig
    Kastrati, Adnan
    Byrne, Robert A.
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [42] Complex Patients Treated With Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents in the Randomized TWENTE Trial: Comparison of 2-Year Clinical Outcome
    Sen, Hanim
    Lam, Ming Kai
    Tandjung, Kenneth
    Lowik, Marije M.
    Stoel, Martin G.
    de Man, Frits H. A. F.
    Louwerenburg, J. W.
    van Houwelingen, Gert K.
    Linssen, Gerard C. M.
    Doggen, Carine J. M.
    Basalus, Mounir W. Z.
    von Birgelen, Clemens
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 85 (01) : 74 - 81
  • [43] Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial
    Yukinori Harada
    Roisin Colleran
    Sebastian Kufner
    Daniele Giacoppo
    Tobias Rheude
    Jonathan Michel
    Salvatore Cassese
    Tareq Ibrahim
    Karl-Ludwig Laugwitz
    Adnan Kastrati
    Robert A. Byrne
    Cardiovascular Diabetology, 15
  • [44] Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
    Serruys, Patrick W.
    Silber, Sigmund
    Garg, Scot
    van Geuns, Robert Jan
    Richardt, Gert
    Buszman, Pawel E.
    Kelbaek, Henning
    van Boven, Adrianus Johannes
    Hofma, Sjoerd H.
    Linke, Axel
    Klauss, Volker
    Wijns, William
    Macaya, Carlos
    Garot, Philippe
    DiMario, Carlo
    Manoharan, Ganesh
    Kornowski, Ran
    Ischinger, Thomas
    Bartorelli, Antonio
    Ronden, Jacintha
    Bressers, Marco
    Gobbens, Pierre
    Negoita, Manuela
    van Leeuwen, Frank
    Windecker, Stephan
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (02): : 136 - 146
  • [45] Comparison of 4.5-Year Outcomes of Bare-Metal and Zotarolimus-Eluting Stents in New York
    Qian, Feng
    Zhong, Ye
    Kheocha-On, Pornchanok
    Hannan, Edward L.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2016, 29 (03) : 265 - 274
  • [46] Comparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea
    Joo Myung Lee
    Tae-Jin Youn
    Jin Joo Park
    Il-Young Oh
    Chang-Hwan Yoon
    Jung-Won Suh
    Young-Seok Cho
    Goo-Yeong Cho
    In-Ho Chae
    Dong-Ju Choi
    BMC Cardiovascular Disorders, 13
  • [47] Comparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea
    Lee, Joo Myung
    Youn, Tae-Jin
    Park, Jin Joo
    Oh, Il-Young
    Yoon, Chang-Hwan
    Suh, Jung-Won
    Cho, Young-Seok
    Cho, Goo-Yeong
    Chae, In-Ho
    Choi, Dong-Ju
    BMC CARDIOVASCULAR DISORDERS, 2013, 13
  • [48] Two-Year Clinical Outcome of Patients With Bifurcation Lesions Treated With Second-generation Zotarolimus-Eluting Resolute Stents and Everolimus-Eluting Xience V Stents in the Randomized TWENTE Trial
    Tandjung, Kenneth
    Sen, Hanim
    Lam, Ming Kai
    Lowik, Marije M.
    van Houwelingen, Gert
    Stoel, Martin G.
    Louwerenburg, Hans W.
    de Man, F.
    Linssen, Gerard C.
    Nijhuis, Rogier
    Nienhuis, Mark B.
    von Birgelen, Clemens
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B61 - B61
  • [49] Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes From the BIONICS and NIREUS Trials
    Konigstein, Maayan
    Smits, Pieter C.
    Love, Michael P.
    Ben-Yehuda, Ori
    Ozan, Melek Ozgu
    Liu, Mengdan
    Perlman, Gidon Y.
    Leon, Martin B.
    Stone, Gregg W.
    Kandzari, David E.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (01) : 86 - 93
  • [50] Clinical outcomes of zotarolimus-eluting stents versus the first generation sirolimus-eluting stents and paclitaxel-eluting stents: A meta-analysis of randomized trials
    Gao Wei
    Yuan Fang
    Ren Yaqi
    Chen Lin
    Wang Ningfu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 157 (01) : 152 - 156
12345